Literature DB >> 21686818

A case report of neuroleptic malignant syndrome.

Shankar Srinivas Kuchibatla1, Sofia Akram Cheema, Kripa S Chakravarthy, Hany George El Sayeh.   

Abstract

A 32-year-old male patient with a history of treatment resistant paranoid schizophrenia developed neuroleptic malignant syndrome (NMS) during changeover of his antipsychotic medication from zuclopenthixol depot to clozapine. This case highlights the difficulties of cross-tapering two antipsychotics-that is, converting from a typical depot medication to an oral atypical antipsychotic.

Entities:  

Year:  2009        PMID： 21686818      PMCID： PMC3027363          DOI： 10.1136/bcr.07.2008.0429

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  3 in total

Review 1.  Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature.

Authors:  J L Karagianis; L C Phillips; K P Hogan; K K LeDrew
Journal:  Ann Pharmacother       Date:  1999-05       Impact factor: 3.154

Review 2.  Neuroleptic malignant syndrome.

Authors:  S N Caroff; S C Mann
Journal:  Med Clin North Am       Date:  1993-01       Impact factor: 5.456

3.  Neuroleptic malignant syndrome variant in a patient receiving donepezil and olanzapine.

Authors:  Tanya C Warwick; Venkata Moningi; Prasuna Jami; Kristy Lucas; Ogochukwu Molokwu; Shalini Moningi
Journal:  Nat Clin Pract Neurol       Date:  2008-01-22
  3 in total
  2 in total

Review 1.  Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.

Authors:  Ramadhan Oruch; Ian F Pryme; Bernt A Engelsen; Anders Lund
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-16       Impact factor: 2.570

2.  Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate.

Authors:  Anish Shouan; Ankit Kumar Sinha; Sandeep Grover
Journal:  Ind Psychiatry J       Date:  2021-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.